Building on this foundation, and motivated by the preclinical evidence that PARPi and radiotherapy can synergistically activate the cGAS-STING pathway to enhance anti-tumor immunity (39), the logical next step is the integration of radiotherapy. Here, STING1 is linked to neoplasm.